Cadrenal Therapeutics, Inc. Proceeds from Convertible Debt
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2024-03-11
- 2022-12-31: Proceeds from Convertible Debt 11 month $1.01M.
- 2022-09-30: Proceeds from Convertible Debt 8 month $1.01M.
- 2022-06-30: Proceeds from Convertible Debt 5 month $548.54K.
- 2022-03-31: Proceeds from Convertible Debt 2 month $498.54K.
| Period end | Proceeds from Convertible Debt 2 month | Proceeds from Convertible Debt 5 month | Proceeds from Convertible Debt 8 month | Proceeds from Convertible Debt 11 month |
|---|---|---|---|---|
| 2022-12-31 | $1.01M 10-K · filed 2024-03-11 | |||
| 2022-09-30 | $1.01M 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | $548.54K 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | $498.54K 10-Q · filed 2023-05-10 |